CHATTANOOGA, Tenn., Feb. 12, 2026 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or the “Company”), today acknowledged the U.S. Department of Commerce’s (“Commerce”) final determinations in the antidumping and countervailing duty investigations covering anode active materials (“AAM”) imported into the U.S. from China. The total amount of the tariffs applicable to AAM imported from China will be at least 160%, subject to a final affirmative determination by the U.S. International Trad ...

German retail leaders have written to Federal Chancellor Friedrich Merz calling for stronger government action to protect the competitiveness of German and European retailers. In a letter ahead of an informal meeting of the European Council, the German Retail Federation (HDE) said unfair competition from traders and online platforms based outside the EU threatens local companies. The appeal highlights concerns over regulatory burdens and market distortions that HDE says put EU firms at a disadvantage. ...

Core Viewpoint - A California court has ordered Medtronic to pay Applied Medical nearly $382 million in damages for monopolistic practices in the bipolar electrosurgical devices market [1] Group 1: Lawsuit Details - Applied Medical filed a lawsuit in February 2023, alleging that Medtronic and certain hospital group purchasing organizations (GPOs) had contracts favoring Medtronic as the 'sole source' for advanced bipolar electrosurgical devices, specifically the LigaSure device [2] - The lawsuit claimed that hospitals faced "financial penalties" and other burdens if they circumvented the GPOs' contracts, which restricted their procurement options [3] Group 2: Court Ruling and Implications - A jury in Los Angeles sided with Applied Medical, confirming that Medtronic used restrictive contracts with healthcare providers [3] - Following the verdict, Applied Medical announced plans to seek injunctive relief to prevent Medtronic from enforcing these restrictions [3] Group 3: Industry Impact - Gary Johnson, a representative for Applied Medical, stated that the ruling validates fair competition and could help hospitals access innovation and value by dismantling complex contractual barriers [4] - Applied Medical emphasized that it was unable to compete effectively with its Voyant device due to Medtronic's restrictive practices and bundling strategies [5] - The company also noted that Medtronic's larger business in other surgical products allegedly conditioned discounts on hospitals purchasing Medtronic's bipolar devices, further stifling competition [6]

Core Viewpoint - Coinbase CEO Brian Armstrong is advocating for legislation that ensures fair competition in the cryptocurrency market, particularly following the postponement of the cryptocurrency market structure bill [1][4]. Group 1: Legislative Advocacy - Armstrong emphasized the need for a "level playing field" in Congress, arguing that American companies should compete fairly without undue influence from banks [2]. - He highlighted the importance of consumers being able to earn higher returns on their stablecoins, specifically advocating for a 3.8% return [2][3]. Group 2: Impact of Coinbase's Withdrawal - Coinbase's withdrawal of support for the cryptocurrency market structure bill led to its indefinite postponement, primarily due to concerns over a rule that would prevent cryptocurrency platforms from offering rewards on idle stablecoin balances [4]. - This rule contrasts with traditional banks that can offer interest on dollar deposits, raising concerns about competitive fairness [4]. Group 3: Financial Implications - Stablecoin rewards are a significant revenue source for Coinbase, linked to interest on USDC reserves shared with Circle [5]. - Following the news, Coinbase shares experienced a 1.01% rebound in after-hours trading after a 6.48% decline during regular trading, indicating volatility in the stock's performance [5].